SYNGENE.BO
Price:
$631.9
Market Cap:
$254.29B
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, Japan, Europe, the United States, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinica...[Read more]
Industry
Biotechnology
IPO Date
2015-08-11
Stock Exchange
BSE
Ticker
SYNGENE.BO
According to Syngene International Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 256.83B. This represents a change of -10.98% compared to the average of 288.50B of the last 4 quarters.
The mean historical Enterprise Value of Syngene International Limited over the last ten years is 183.45B. The current 256.83B Enterprise Value has changed 13.90% with respect to the historical average. Over the past ten years (40 quarters), SYNGENE.BO's Enterprise Value was at its highest in in the September 2024 quarter at 365.22B. The Enterprise Value was at its lowest in in the March 2016 quarter at 82.24B.
Average
183.45B
Median
173.13B
Minimum
81.14B
Maximum
290.36B
Discovering the peaks and valleys of Syngene International Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.22%
Maximum Annual Enterprise Value = 290.36B
Minimum Annual Increase = -17.48%
Minimum Annual Enterprise Value = 81.14B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 290.36B | 0.49% |
| 2024 | 288.95B | 16.92% |
| 2023 | 247.12B | -0.54% |
| 2022 | 248.47B | 11.24% |
| 2021 | 223.36B | 120.22% |
| 2020 | 101.43B | -17.48% |
| 2019 | 122.91B | 0.81% |
| 2018 | 121.92B | 12.05% |
| 2017 | 108.81B | 34.10% |
| 2016 | 81.14B | 31.69% |
The current Enterprise Value of Syngene International Limited (SYNGENE.BO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
275.48B
5-year avg
259.65B
10-year avg
183.45B
Syngene International Limited’s Enterprise Value is less than Piramal Pharma Limited (277.44B), greater than Dr. Lal PathLabs Limited (243.53B), greater than Dr. Lal PathLabs Limited (243.53B), greater than Piramal Enterprises Limited (254.86B), less than J. B. Chemicals & Pharmaceuticals Limited (286.36B), less than J. B. Chemicals & Pharmaceuticals Limited (286.36B), less than Inventurus Knowledge Solutions Ltd. (277.60B), greater than Sagility India Limited (235.61B), greater than Sagility India Limited (235.61B), less than Inventurus Knowledge Solutions Ltd. (277.60B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 277.44B | $234.14B | |
| 243.53B | $250.13B | |
| 243.53B | $249.54B | |
| 254.86B | $254.86B | |
| 286.36B | $286.89B | |
| 286.36B | $285.57B | |
| 277.60B | $272.19B | |
| 235.61B | $226.81B | |
| 235.61B | $228.36B | |
| 277.60B | $272.23B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syngene International Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Syngene International Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Syngene International Limited's Enterprise Value?
What is the highest Enterprise Value for Syngene International Limited (SYNGENE.BO)?
What is the 3-year average Enterprise Value for Syngene International Limited (SYNGENE.BO)?
What is the 5-year average Enterprise Value for Syngene International Limited (SYNGENE.BO)?
How does the current Enterprise Value for Syngene International Limited (SYNGENE.BO) compare to its historical average?